Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11836)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vaccaro V, Sperduti I, Vari S, Bria E, Melisi D, Garufi C, Nuzzo C, Scarpa A, Tortora G, Cognetti F, Reni M, Milella M. Metastatic pancreatic cancer: Is there a light at the end of the tunnel? World J Gastroenterol 2015; 21(16): 4788-4801 [PMID: 25944992 DOI: 10.3748/wjg.v21.i16.4788] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i16/4788.htm |
| Number | Citing Articles |
| 1 |
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & Therapeutics 2015; 155: 80 doi: 10.1016/j.pharmthera.2015.08.006
|
| 2 |
Eleni Kotsampasakou, Gerhard F. Ecker. Transporters as Drug Targets. Methods and Principles in Medicinal Chemistry 2017; : 271 doi: 10.1002/9783527679430.ch12
|
| 3 |
Aleksandra Adamska, Marco Falasca. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?. World Journal of Gastroenterology 2018; 24(29): 3222-3238 doi: 10.3748/wjg.v24.i29.3222
|
| 4 |
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic Cancer. Cancers 2017; 9(12): 122 doi: 10.3390/cancers9090122
|
| 5 |
Russell W. Smith, Jeffrey D. Coleman, Jerry T. Thompson, John P. Vanden Heuvel. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells. Biochemistry and Biophysics Reports 2016; 8: 395 doi: 10.1016/j.bbrep.2016.10.014
|
| 6 |
Wojciech Marlicz, Katarzyna Sielatycka, Karol Serwin, Ewa Kubis, Marta Tkacz, Rafał Głuszko, Andrzej Białek, Teresa Starzyńska, Mariusz Z. Ratajczak. Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood. Oncology Reports 2016; 36(6): 3635 doi: 10.3892/or.2016.5179
|
| 7 |
Lindsay A. Bliss, Mariam F. Eskander, Tara S. Kent, Ammara A. Watkins, Susanna W.L. de Geus, Alessandra Storino, Sing Chau Ng, Mark P. Callery, A. James Moser, Jennifer F. Tseng. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. HPB 2016; 18(8): 671 doi: 10.1016/j.hpb.2016.05.008
|
| 8 |
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
|
| 9 |
Ágnes Czikora, Katalin Erdélyi, Tamás Ditrói, Noémi Szántó, Eszter Petra Jurányi, Szilárd Szanyi, József Tóvári, Tamás Strausz, Péter Nagy. Cystathionine β-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells. Redox Biology 2022; 57: 102505 doi: 10.1016/j.redox.2022.102505
|
| 10 |
Carolina Torres, Paul J. Grippo. Pancreatic cancer subtypes: a roadmap for precision medicine. Annals of Medicine 2018; 50(4): 277 doi: 10.1080/07853890.2018.1453168
|
| 11 |
Ayesha Manzur, Adeolu Oluwasanmi, Darren Moss, Anthony Curtis, Clare Hoskins. Nanotechnologies in Pancreatic Cancer Therapy. Pharmaceutics 2017; 9(4): 39 doi: 10.3390/pharmaceutics9040039
|
| 12 |
Isabella Frigerio, Paolo Regi, Alessandro Giardino, Filippo Scopelliti, Roberto Girelli, Claudio Bassi, Stefano Gobbo, Paolo Tinazzi Martini, Paola Capelli, Mirko D’Onofrio, Giuseppe Malleo, Laura Maggino, Elena Viviani, Giovanni Butturini. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?. Annals of Surgical Oncology 2017; 24(8): 2397 doi: 10.1245/s10434-017-5885-4
|
| 13 |
Qing-Hua Liu, Hong-Mei Yong, Qing-Xin Zhuang, Xu-Ping Zhang, Ping-Fu Hou, Yan-Su Chen, Ming-Hua Zhu, Jin Bai. Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer. Investigational New Drugs 2020; 38(2): 350 doi: 10.1007/s10637-019-00785-5
|
| 14 |
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
|
| 15 |
Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti. Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer. Biomolecules 2021; 11(6): 780 doi: 10.3390/biom11060780
|
| 16 |
K. Vanova, S. Boukalova, H. Gbelcova, L. Muchova, J. Neuzil, R. Gurlich, T. Ruml, L. Vitek. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2343-9
|
| 17 |
Aleksandra Adamska, Riccardo Ferro, Rossano Lattanzio, Emily Capone, Alice Domenichini, Verena Damiani, Giovanna Chiorino, Begum Gokcen Akkaya, Kenneth J. Linton, Vincenzo De Laurenzi, Gianluca Sala, Marco Falasca. ABCC3 is a novel target for the treatment of pancreatic cancer. Advances in Biological Regulation 2019; 73: 100634 doi: 10.1016/j.jbior.2019.04.004
|
| 18 |
Ashika D. Maharaj, Sue M. Evans, Liane J. Ioannou, Daniel Croagh, Arul Earnest, Jennifer F. Holland, Charles H.C. Pilgrim, Rachel E. Neale, David Goldstein, James G. Kench, Neil D. Merrett, Kate White, Elizabeth A. Burmeister, Peter M. Evans, Theresa M. Hayes, Nezor Houli, Brett Knowles, Trevor Leong, Mehrdad Nikfarjam, Jennifer Philip, Maddy Quinn, Jeremy Shapiro, Marty D. Smith, John B. Spillane, Rachel Wong, John R. Zalcberg. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. HPB 2022; 24(6): 950 doi: 10.1016/j.hpb.2021.11.005
|
| 19 |
Concetta Panebianco, Edgar Kelman, Kristel Vene, Domenica Gioffreda, Francesca Tavano, Raivo Vilu, Fulvia Terracciano, Illar Pata, Kaarel Adamberg, Angelo Andriulli, Valerio Pazienza. Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 56(1): 138 doi: 10.1515/cclm-2016-1158
|
| 20 |
Arsheed A. Ganaie, Aijaz Parray, Tabish Hussain, Ashraf Shabaneh, Anmbreen Jamroze, Marina G. Ferrari, Lei Wang, D. Joshua Liao, Shahriar Koochekpour, Sanjeev Nanda, Jinhua Wang, Yibin Deng, Sergio A Gradilone, Edward H. Hinchcliffe, Badrinath R. Konety, Mohammad Saleem. Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression. Translational Oncology 2019; 12(8): 1056 doi: 10.1016/j.tranon.2019.05.002
|
| 21 |
Marco Falasca, Minkyoung Kim, Ilaria Casari. Pancreatic cancer: Current research and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 123 doi: 10.1016/j.bbcan.2016.01.001
|
| 22 |
Qi Li, Zijian Feng, Ruyi Miao, Xun Liu, Chenxi Liu, Zhen Liu. Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-021-02478-x
|
| 23 |
Richard A. Hubner, Antonio Cubillo, Jean-Frédéric Blanc, Davide Melisi, Daniel D. Von Hoff, Andrea Wang-Gillam, Li-Tzong Chen, Claus Becker, Khalid Mamlouk, Bruce Belanger, Yoojung Yang, Floris A. de Jong, Jens T. Siveke. Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. European Journal of Cancer 2019; 106: 24 doi: 10.1016/j.ejca.2018.09.029
|
| 24 |
Francesca Simionato, Camilla Zecchetto, Valeria Merz, Alessandro Cavaliere, Simona Casalino, Marina Gaule, Mirko D’Onofrio, Giuseppe Malleo, Luca Landoni, Alessandro Esposito, Giovanni Marchegiani, Luca Casetti, Massimiliano Tuveri, Salvatore Paiella, Filippo Scopelliti, Alessandro Giardino, Isabella Frigerio, Paolo Regi, Paola Capelli, Stefano Gobbo, Armando Gabbrielli, Laura Bernardoni, Vita Fedele, Irene Rossi, Cristiana Piazzola, Serena Giacomazzi, Martina Pasquato, Morena Gianfortone, Stefano Milleri, Michele Milella, Giovanni Butturini, Roberto Salvia, Claudio Bassi, Davide Melisi. A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial. Therapeutic Advances in Medical Oncology 2020; 12: 175883592094796 doi: 10.1177/1758835920947969
|
| 25 |
Paola Cappello, Elisabetta Tonoli, Roberta Curto, Daniele Giordano, Mirella Giovarelli, Francesco Novelli. Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response. OncoImmunology 2016; 5(5): e1112940 doi: 10.1080/2162402X.2015.1112940
|
| 26 |
Liudmila G. Zhukova, Dmitry S. Bordin, Elena A. Dubtsova, Matvey A. Ilin, Mariia A. Kiriukova, Polina S. Feoktistova, Vyacheslav I. Egorov. How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review. Journal of Modern Oncology 2024; 25(4) doi: 10.26442/18151434.2023.4.202541
|
| 27 |
Berna Akkus Yildirim, Yurday Özdemir, Tamer Colakoglu, Erkan Topkan. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy. Pancreatology 2016; 16(4): 599 doi: 10.1016/j.pan.2016.03.006
|
| 28 |
Ella Rimmer, Sadaf Rashid, Igor Kraev, Francesc Miralles, Androulla Elia. Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment. International Journal of Molecular Sciences 2022; 23(14): 7810 doi: 10.3390/ijms23147810
|
| 29 |
Haseeb Zubair, Shafquat Azim, Sanjeev Kumar Srivastava, Aamir Ahmad, Arun Bhardwaj, Mohammad Aslam Khan, Girijesh Kumar Patel, Sumit Arora, James Elliot Carter, Seema Singh, Ajay Pratap Singh. Glucose Metabolism Reprogrammed by Overexpression of IKKϵ Promotes Pancreatic Tumor Growth. Cancer Research 2016; 76(24): 7254 doi: 10.1158/0008-5472.CAN-16-1666
|
| 30 |
Eun Young Kim, Soo Ho Lee, Tae Ho Hong. Palliative laparoscopic Roux-en-Y choledochojejunostomy as a feasible treatment option for malignant distal biliary obstruction. Surgery Today 2022; 52(11): 1568 doi: 10.1007/s00595-022-02513-8
|
| 31 |
Nadia Hitchen, Nick R. Waldron, Sanjeev Deva, Michael Findlay, Benjamin Lawrence. Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma. Asia-Pacific Journal of Clinical Oncology 2023; 19(5) doi: 10.1111/ajco.13845
|
| 32 |
C Carbone, G Piro, N Gaianigo, F Ligorio, R Santoro, V Merz, F Simionato, C Zecchetto, G Falco, G Conti, P T Kamga, M Krampera, F Di Nicolantonio, L De Franceschi, A Scarpa, G Tortora, D Melisi. Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling. International Journal of Obesity 2018; 42(3): 334 doi: 10.1038/ijo.2017.285
|
| 33 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
|
| 34 |
Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study. International Journal of Molecular Sciences 2019; 20(21): 5250 doi: 10.3390/ijms20215250
|
| 35 |
Martin Wartenberg, Irene Centeno, Stefan Haemmig, Erik Vassella, Inti Zlobec, José A. Galván, Maja Neuenschwander, Cornelia Schlup, Beat Gloor, Alessandro Lugli, Aurel Perren, Eva Karamitopoulou. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. European Journal of Cancer 2016; 65: 80 doi: 10.1016/j.ejca.2016.06.013
|
| 36 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|
| 37 |
Nai-Jung Chiang, Kelvin K. Tsai, Chin-Fu Hsiao, Shih-Hung Yang, Hui-Hua Hsiao, Wen-Chi Shen, Chiun Hsu, Yu-Lin Lin, Jen-Shi Chen, Yan-Shen Shan, Li-Tzong Chen. A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study. European Journal of Cancer 2020; 124: 123 doi: 10.1016/j.ejca.2019.10.023
|
| 38 |
Nai-Jung Chiang, Jang-Yang Chang, Yan-Shen Shan, Li-Tzong Chen. Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer. Expert Opinion on Pharmacotherapy 2016; 17(10): 1413 doi: 10.1080/14656566.2016.1183646
|
| 39 |
Raffaela Santoro, Marco Zanotto, Francesca Simionato, Camilla Zecchetto, Valeria Merz, Chiara Cavallini, Geny Piro, Fabio Sabbadini, Federico Boschi, Aldo Scarpa, Davide Melisi. Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics 2020; 19(1): 247 doi: 10.1158/1535-7163.MCT-19-0270
|
| 40 |
Ademar Dantas Cunha Júnior, Arinilda Campos Bragagnoli, Felipe Osório Costa, José Barreto Campello Carvalheira. Repurposing metformin for the treatment of gastrointestinal cancer. World Journal of Gastroenterology 2021; 27(17): 1883-1904 doi: 10.3748/wjg.v27.i17.1883
|
| 41 |
Ilaria Passacantilli, Valentina Panzeri, Pamela Bielli, Donatella Farini, Emanuela Pilozzi, Gianfranco Delle Fave, Gabriele Capurso, Claudio Sette. Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells. Cell Death & Disease 2017; 8(11): e3168 doi: 10.1038/cddis.2017.562
|
| 42 |
Alexandria Turner, Danielle R. Bond, Quan V. Vuong, Anita Chalmers, Emma L. Beckett, Judith Weidenhofer, Christopher J. Scarlett. Elaeocarpus reticulatus fruit extracts reduce viability and induce apoptosis in pancreatic cancer cells in vitro. Molecular Biology Reports 2020; 47(3): 2073 doi: 10.1007/s11033-020-05307-8
|
| 43 |
Wenhua Li, Ling Liu, Di Liu, Shimao Jin, Yisha Yang, Wei Tang, Lei Gong. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications 2016; 472(1): 156 doi: 10.1016/j.bbrc.2016.02.087
|
| 44 |
Bengt Glimelius. Any progress in pancreatic cancer?. Acta Oncologica 2016; 55(3): 255 doi: 10.3109/0284186X.2015.1126350
|
| 45 |
Georgios Gemenetzis, Vincent P. Groot, Alex B. Blair, Ding Ding, Sameer S. Thakker, Elliot K. Fishman, John L. Cameron, Martin A. Makary, Matthew J. Weiss, Christopher L. Wolfgang, Jin He. Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma. Journal of Surgical Oncology 2018; 118(8): 1277 doi: 10.1002/jso.25288
|
| 46 |
Chiara Caparello, Laura L Meijer, Ingrid Garajova, Alfredo Falcone, Tessa Y Le Large, Niccola Funel, Geert Kazemier, Godefridus J Peters, Enrico Vasile, Elisa Giovannetti. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World Journal of Gastroenterology 2016; 22(31): 6987-7005 doi: 10.3748/wjg.v22.i31.6987
|
| 47 |
Eunice Eugenia Robless, Justin Andrew Howard, Ilaria Casari, Marco Falasca. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer. Cancer Letters 2021; 501: 55 doi: 10.1016/j.canlet.2020.12.005
|
| 48 |
Antonella Argentiero, Angela Calabrese, Angela Monica Sciacovelli, Sabina Delcuratolo, Antonio Giovanni Solimando, Oronzo Brunetti. Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8679751
|
| 49 |
Paola Cappello, Claudia Curcio, Giorgia Mandili, Cecilia Roux, Sara Bulfamante, Francesco Novelli. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. Cancers 2018; 10(2): 51 doi: 10.3390/cancers10020051
|
| 50 |
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, Denis Pezet, Gael Deplanque, Martin Fuchs, Jorg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael M. F. Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. British Journal of Cancer 2018; 119(10): 1208 doi: 10.1038/s41416-018-0246-z
|
| 51 |
Roberto Ferrara, Francesca Simionato, Chiara Ciccarese, Elisabetta Grego, Sara Cingarlini, Roberto Iacovelli, Emilio Bria, Giampaolo Tortora, Davide Melisi. The development of PARP as a successful target for cancer therapy. Expert Review of Anticancer Therapy 2018; 18(2): 161 doi: 10.1080/14737140.2018.1419870
|